Marco Silvio Passafaro

Title: **Marco Silvio Passafaro: Innovations in Targeted Delivery Systems**

Introduction

Marco Silvio Passafaro is a prominent inventor based in Thayngen, Switzerland, known for his contributions to the field of targeted delivery systems. With a total of six patents to his name, Passafaro is dedicated to advancing medical applications through innovative inventions.

Latest Patents

One of his latest patents focuses on "Targeting Aminoacid Lipids." This invention is directed to carrier systems consisting of ether-lipids conjugated to one or more bioactive ligands. These ligands are exposed on the carrier system's surface for targeted delivery and antigen display systems. The invention allows for the encapsulation or adsorption of additional bioactive agents within the carrier system. It has promising applications in delivering bioactive agents to specific tissues or cells and in antigen display systems used for studying, diagnosing, and treating various traits, diseases, and conditions that respond to bioactive agents.

Career Highlights

Marco Silvio Passafaro has held significant positions in several key companies, including Merck Patent GmbH and Cardiome Pharma Corporation. His work has substantially impacted the medical field, particularly in developing sophisticated drug delivery systems that improve treatment outcomes.

Collaborations

Throughout his career, Passafaro has collaborated with notable professionals such as Michael Wilhelm Platscher and Raymond Behrendt. These partnerships have enhanced his innovative capabilities and facilitated the advancement of his research projects.

Conclusion

Marco Silvio Passafaro continues to make significant strides in innovation, particularly in the realm of targeted delivery systems in medical applications. His patented inventions position him as a noteworthy figure in the field, dedicated to improving healthcare outcomes through his groundbreaking work.